Progyny Tax Provision vs Income Tax Expense Analysis

PGNY Stock

USD 28.09 0.54 1.96%

Progyny financial indicator trend analysis is much more than just breaking down Progyny prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Progyny is a good investment. Please check the relationship between Progyny Tax Provision and its Income Tax Expense accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Progyny. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Progyny Stock please use our How to Invest in Progyny guide.

Tax Provision vs Income Tax Expense

Tax Provision vs Income Tax Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Progyny Tax Provision account and Income Tax Expense. At this time, the significance of the direction appears to have totally related.

The correlation between Progyny's Tax Provision and Income Tax Expense is 1.0. Overlapping area represents the amount of variation of Tax Provision that can explain the historical movement of Income Tax Expense in the same time period over historical financial statements of Progyny, assuming nothing else is changed. The correlation between historical values of Progyny's Tax Provision and Income Tax Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Tax Provision of Progyny are associated (or correlated) with its Income Tax Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Tax Expense has no effect on the direction of Tax Provision i.e., Progyny's Tax Provision and Income Tax Expense go up and down completely randomly.

Correlation Coefficient

1.0

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Income Tax Expense

Most indicators from Progyny's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Progyny current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Progyny. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Progyny Stock please use our How to Invest in Progyny guide.At this time, Progyny's Tax Provision is fairly stable compared to the past year. Discontinued Operations is likely to rise to about 7 M in 2024, whereas Selling General Administrative is likely to drop slightly above 59 M in 2024.

	2023	2024 (projected)
Discontinued Operations	6.6M	7.0M
Interest Income	732.6K	421.8K

Discontinued Operations Interest Income

Progyny fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Other Current Assets
Total Assets		0.9	0.27	0.9	1.0	-0.72	0.97	0.99	0.94	-0.83	0.99	0.99	0.82	0.87	0.84	0.96	-0.79	0.99	0.89	-0.79	0.8	0.9	-0.79	0.48	0.95	0.91
Short Long Term Debt Total	0.9		0.0	0.7	0.91	-0.5	0.83	0.92	0.79	-0.64	0.87	0.85	0.64	0.65	0.59	0.8	-0.89	0.95	0.67	-0.89	0.66	0.73	-0.89	0.67	0.84	0.97
Other Current Liab	0.27	0.0		0.46	0.25	-0.49	0.41	0.22	0.14	-0.6	0.19	0.34	0.6	0.43	0.41	0.21	0.19	0.18	0.48	0.19	0.55	0.45	0.19	0.09	0.44	-0.06
Total Current Liabilities	0.9	0.7	0.46		0.9	-0.74	0.92	0.88	0.85	-0.85	0.9	0.92	0.89	0.97	0.94	0.9	-0.48	0.85	0.99	-0.48	0.86	0.9	-0.48	0.43	0.9	0.71
Total Stockholder Equity	1.0	0.91	0.25	0.9		-0.72	0.97	0.99	0.93	-0.83	0.98	0.99	0.82	0.86	0.83	0.96	-0.8	0.99	0.89	-0.8	0.8	0.9	-0.8	0.51	0.95	0.91
Other Liab	-0.72	-0.5	-0.49	-0.74	-0.72		-0.81	-0.72	-0.56	0.85	-0.66	-0.74	-0.83	-0.71	-0.64	-0.67	0.41	-0.69	-0.72	0.41	-0.86	-0.78	0.41	-0.39	-0.84	-0.58
Net Tangible Assets	0.97	0.83	0.41	0.92	0.97	-0.81		0.95	0.87	-0.93	0.94	0.97	0.93	0.91	0.87	0.94	-0.67	0.94	0.92	-0.67	0.91	0.95	-0.67	0.54	0.99	0.82
Property Plant And Equipment Net	0.99	0.92	0.22	0.88	0.99	-0.72	0.95		0.9	-0.79	0.98	0.97	0.79	0.86	0.78	0.93	-0.82	0.99	0.85	-0.82	0.79	0.92	-0.82	0.48	0.94	0.93
Current Deferred Revenue	0.94	0.79	0.14	0.85	0.93	-0.56	0.87	0.9		-0.69	0.97	0.95	0.69	0.83	0.87	0.97	-0.76	0.9	0.87	-0.76	0.61	0.79	-0.76	0.28	0.82	0.82
Net Debt	-0.83	-0.64	-0.6	-0.85	-0.83	0.85	-0.93	-0.79	-0.69		-0.77	-0.84	-0.99	-0.85	-0.83	-0.8	0.42	-0.78	-0.86	0.42	-0.96	-0.88	0.42	-0.57	-0.95	-0.6
Retained Earnings	0.99	0.87	0.19	0.9	0.98	-0.66	0.94	0.98	0.97	-0.77		0.98	0.77	0.89	0.86	0.98	-0.79	0.96	0.89	-0.79	0.74	0.89	-0.79	0.38	0.9	0.89
Accounts Payable	0.99	0.85	0.34	0.92	0.99	-0.74	0.97	0.97	0.95	-0.84	0.98		0.83	0.89	0.87	0.96	-0.75	0.97	0.92	-0.75	0.8	0.91	-0.75	0.41	0.95	0.86
Cash	0.82	0.64	0.6	0.89	0.82	-0.83	0.93	0.79	0.69	-0.99	0.77	0.83		0.89	0.87	0.81	-0.37	0.77	0.9	-0.37	0.97	0.89	-0.37	0.59	0.94	0.58
Non Current Assets Total	0.87	0.65	0.43	0.97	0.86	-0.71	0.91	0.86	0.83	-0.85	0.89	0.89	0.89		0.95	0.91	-0.43	0.8	0.96	-0.43	0.87	0.94	-0.43	0.34	0.87	0.64
Non Currrent Assets Other	0.84	0.59	0.41	0.94	0.83	-0.64	0.87	0.78	0.87	-0.83	0.86	0.87	0.87	0.95		0.92	-0.39	0.75	0.97	-0.39	0.79	0.84	-0.39	0.32	0.83	0.57
Other Assets	0.96	0.8	0.21	0.9	0.96	-0.67	0.94	0.93	0.97	-0.8	0.98	0.96	0.81	0.91	0.92		-0.7	0.91	0.91	-0.7	0.75	0.89	-0.7	0.34	0.89	0.8
Long Term Debt	-0.79	-0.89	0.19	-0.48	-0.8	0.41	-0.67	-0.82	-0.76	0.42	-0.79	-0.75	-0.37	-0.43	-0.39	-0.7		-0.86	-0.45	1.0	-0.38	-0.56	1.0	-0.37	-0.66	-0.93
Cash And Short Term Investments	0.99	0.95	0.18	0.85	0.99	-0.69	0.94	0.99	0.9	-0.78	0.96	0.97	0.77	0.8	0.75	0.91	-0.86		0.83	-0.86	0.77	0.85	-0.86	0.55	0.93	0.96
Net Receivables	0.89	0.67	0.48	0.99	0.89	-0.72	0.92	0.85	0.87	-0.86	0.89	0.92	0.9	0.96	0.97	0.91	-0.45	0.83		-0.45	0.85	0.88	-0.45	0.42	0.89	0.67
Good Will	-0.79	-0.89	0.19	-0.48	-0.8	0.41	-0.67	-0.82	-0.76	0.42	-0.79	-0.75	-0.37	-0.43	-0.39	-0.7	1.0	-0.86	-0.45		-0.38	-0.56	1.0	-0.37	-0.66	-0.93
Common Stock Total Equity	0.8	0.66	0.55	0.86	0.8	-0.86	0.91	0.79	0.61	-0.96	0.74	0.8	0.97	0.87	0.79	0.75	-0.38	0.77	0.85	-0.38		0.89	-0.38	0.64	0.93	0.61
Common Stock Shares Outstanding	0.9	0.73	0.45	0.9	0.9	-0.78	0.95	0.92	0.79	-0.88	0.89	0.91	0.89	0.94	0.84	0.89	-0.56	0.85	0.88	-0.56	0.89		-0.56	0.36	0.93	0.71
Long Term Debt Total	-0.79	-0.89	0.19	-0.48	-0.8	0.41	-0.67	-0.82	-0.76	0.42	-0.79	-0.75	-0.37	-0.43	-0.39	-0.7	1.0	-0.86	-0.45	1.0	-0.38	-0.56		-0.37	-0.66	-0.93
Non Current Liabilities Total	0.48	0.67	0.09	0.43	0.51	-0.39	0.54	0.48	0.28	-0.57	0.38	0.41	0.59	0.34	0.32	0.34	-0.37	0.55	0.42	-0.37	0.64	0.36	-0.37		0.6	0.57
Capital Surpluse	0.95	0.84	0.44	0.9	0.95	-0.84	0.99	0.94	0.82	-0.95	0.9	0.95	0.94	0.87	0.83	0.89	-0.66	0.93	0.89	-0.66	0.93	0.93	-0.66	0.6		0.81
Other Current Assets	0.91	0.97	-0.06	0.71	0.91	-0.58	0.82	0.93	0.82	-0.6	0.89	0.86	0.58	0.64	0.57	0.8	-0.93	0.96	0.67	-0.93	0.61	0.71	-0.93	0.57	0.81

Click cells to compare fundamentals

Progyny Account Relationship Matchups

Progyny fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	150.4M	253.9M	358.1M	543.0M	756.6M	794.5M
Other Current Liab	16.8M	34.3M	2.2M	49.0M	1.2M	1.1M
Total Current Liabilities	36.2M	77.8M	98.8M	159.5M	186.0M	95.3M
Total Stockholder Equity	114.3M	166.9M	251.8M	377.0M	553.4M	581.1M
Net Tangible Assets	100.0M	153.9M	239.3M	365.0M	419.7M	440.7M
Property Plant And Equipment Net	3.1M	12.1M	12.8M	15.3M	27.8M	29.2M
Net Debt	(80.4M)	(62.0M)	(84.0M)	(112.4M)	(77.9M)	(81.8M)
Retained Earnings	(113.5M)	(68.2M)	(2.4M)	27.9M	90.0M	94.5M
Accounts Payable	19.4M	43.5M	61.4M	109.3M	125.4M	131.7M
Cash	80.4M	70.3M	91.4M	120.1M	97.3M	73.0M
Non Current Assets Total	18.0M	63.7M	99.5M	109.1M	116.2M	69.4M
Non Currrent Assets Other	652K	573K	2.9M	4.0M	3.4M	1.9M
Other Assets	652K	8.2M	74.2M	81.9M	94.2M	98.9M
Cash And Short Term Investments	80.4M	109.3M	119.4M	189.3M	371.1M	389.6M
Net Receivables	47.1M	75.7M	134.6M	240.1M	241.9M	121.6M
Common Stock Shares Outstanding	83.6M	99.1M	100.4M	100.0M	100.7M	101.6M
Liabilities And Stockholders Equity	150.4M	253.9M	358.1M	543.0M	756.6M	794.5M
Non Current Liabilities Total	19.4M	9.2M	7.4M	6.5M	17.2M	10.4M
Capital Surpluse	228.8M	236.1M	255.3M	349.5M	402.0M	422.1M
Other Current Assets	5.0M	5.3M	4.6M	4.5M	27.5M	28.8M
Other Stockholder Equity	227.7M	235.1M	254.3M	348.5M	460.6M	242.6M
Total Liab	36.2M	87.0M	106.2M	166.0M	203.2M	102.6M
Net Invested Capital	114.3M	166.9M	251.8M	377.0M	553.4M	581.1M
Property Plant And Equipment Gross	3.1M	12.1M	12.8M	15.3M	33.1M	34.8M
Total Current Assets	132.4M	190.2M	258.5M	433.9M	640.4M	672.4M
Accumulated Other Comprehensive Income	(150.4M)	1K	(93K)	501K	2.8M	3.0M
Net Working Capital	96.3M	112.4M	159.7M	274.3M	454.5M	477.2M
Intangible Assets	2.4M	1.2M	599K	99K	89.1K	84.6K
Property Plant Equipment	3.1M	3.4M	12.8M	8.4M	9.6M	5.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
CRM	Salesforce
MSFT	Microsoft

When determining whether Progyny offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Progyny's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Progyny Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Progyny Stock:

How To Invest In Progyny

Details

Is Progyny Stock a good investment?

Details

What is Progyny's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Progyny. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Progyny Stock please use our How to Invest in Progyny guide.

You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Progyny Stock analysis

When running Progyny's price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.

	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets

Is Progyny's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Progyny. If investors know Progyny will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Progyny listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.06)

Earnings Share

0.61

Revenue Per Share

11.583

Quarterly Revenue Growth

0.076

Return On Assets

0.0569

The market value of Progyny is measured differently than its book value, which is the value of Progyny that is recorded on the company's balance sheet. Investors also form their own opinion of Progyny's value that differs from its market value or its book value, called intrinsic value, which is Progyny's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Progyny's market value can be influenced by many factors that don't directly affect Progyny's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Progyny's value and its price as these two are different measures arrived at by different means. Investors typically determine if Progyny is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Progyny's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Progyny Tax Provision vs Income Tax Expense Analysis

Tax Provision vs Income Tax Expense

Tax Provision vs Income Tax Expense Correlation Analysis

Correlation Coefficient

Tax Provision

Income Tax Expense

Progyny fundamental ratios Correlations

Progyny Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Progyny fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Progyny Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Good Will	+ 1.0	Long Term Debt
Long Term Debt Total	+ 1.0	Long Term Debt
Long Term Debt Total	+ 1.0	Good Will
Property Plant And Equipment Net	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Assets

Cash	- 0.99	Net Debt
Common Stock Total Equity	- 0.96	Net Debt
Capital Surpluse	- 0.95	Net Debt
Other Current Assets	- 0.93	Long Term Debt Total
Other Current Assets	- 0.93	Good Will
Other Current Assets	- 0.93	Long Term Debt